0.00Open57.31Pre Close0 Volume0 Open Interest120.00Strike Price0.00Turnover213.65%IV17.95%PremiumDec 20, 2024Expiry Date43.60Intrinsic Value100Multiplier4DDays to Expiry13.72Extrinsic Value100Contract SizeAmericanOptions Type-0.9715Delta0.0040Gamma1.74Leverage Ratio-0.0999Theta-0.0084Rho-1.69Eff Leverage0.0052Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet